OSBPL2

protein-coding

oxysterol binding protein like 2, the group of Oxysterol binding proteins

Gene summary

This gene encodes a member of the oxysterol-binding protein (OSBP) family, a group of intracellular lipid receptors. Most members contain an N-terminal pleckstrin homology domain and a highly conserved C-terminal OSBP-like sterol-binding domain, although the encoded protein contains only the sterol-binding domain. In vitro studies have shown that the encoded protein can bind strongly to phosphatic acid and weakly to phosphatidylinositol 3-phosphate, but cannot bind to 25-hydroxycholesterol. The protein associates with the Golgi apparatus. Transcript variants encoding different isoforms have been described. [provided by RefSeq, Sep 2014]

MANE transcript

NM_144498.4

Inheritance

AD

ClinVar variants

P:6U:106B:61

Top phenotype

Deafness, autosomal dominant 67

gnomAD constraint

pLI —, LoF o/e 0.26

Max pathogenic AF

—

Genomic locus

chr20:62,231,922-62,296,213

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~64.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

nonsyndromic genetic hearing lossMODERATE

Inheritance Pattern: AD

Disease ID:MONDO:0019497

Submitter: ClinGen

OSBPL2 was reported with autosomal dominant nonsyndromic hearing loss in 2015 (Xing et al., PMID: 25077649). At least 4 unique variants (missense, frameshift) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 4 probands in 3 publications (PMID: 25077649, 25759012, 30894143). Variants in this gene segregated with disease in 31 additional family members. This gene-disease association is supported by animal models and expression studies. In summary, there is moderate evidence to support this gene-disease association. While more evidence is needed to establish this association definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Hearing Loss Working Group on 2/6/2020.

autosomal dominant nonsyndromic hearing lossSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0019587

Submitter: Orphanet

autosomal dominant nonsyndromic hearing loss 67STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014594

Submitter: PanelApp Australia

autosomal dominant nonsyndromic hearing loss 67STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014594

Submitter: Labcorp Genetics (formerly Invitae)

autosomal dominant nonsyndromic hearing loss 67MODERATE

Inheritance Pattern: AD

Disease ID:MONDO:0014594

Submitter: Ambry Genetics

Clinical Genomic Database (CGD)

Deafness, autosomal dominant 67AD

Manifestation: Audiologic/Otolaryngologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 25077649; 25759012Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to OSBPL2 variants in ClinVar

5 Conditions Cataloged
not providedTotal: 214
Inborn genetic diseasesTotal: 48
not specifiedTotal: 23
OSBPL2-related disorderTotal: 14
Autosomal dominant nonsyndromic hearing loss 67Total: 8

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_144498.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
48
clinvar
3
clinvar
56
missense
92
clinvar
8
clinvar
2
clinvar
102
nonsense
2
clinvar
2
start loss
0
frameshift
5
clinvar
1
clinvar
2
clinvar
8
splice donor/acceptor (+/-2bp)
5
clinvar
5
Total51106565173
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 80 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_144498.4RefSeqNP_653081.113MANE Select
ENST00000313733.9EnsemblENSP00000316649.313MANE Select
NM_001278649.3RefSeqNP_001265578.19Standard
NM_001363878.2RefSeqNP_001350807.110Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Metabolism of lipids
  • Metabolism
  • Synthesis of bile acids and bile salts
  • Bile acid and bile salt metabolism
  • Metabolism of steroids

Biological Process

  • bile acid biosynthetic process
  • sterol transport

Molecular Function

  • protein binding
  • lipid binding
  • sterol transporter activity
  • cholesterol binding
  • sterol binding

Cellular Component

  • cytosol
  • membrane
  • intracellular membrane-bounded organelle

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000313733
Coding exons
13
Length
57689
Individuals with no LoFs
125734
Homozygous LoFs
0
Heterozygous LoFs
14
Defined
125748
p
0.0000557
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.971972920.6750.00001713194
Missense (PolyPhen)56142.430.393181473
Synonymous0.6081121200.9300.00000857858
Loss of Function3.61727.40.2560.00000125320

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000620.000058rare
Ashkenazi Jewish0.000200.00020rare
East Asian0.0000540.000054rare
Finnish0.0000460.000046rare
European (Non-Finnish)0.0000700.000062rare
South Asian0.0000330.000033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Binds phospholipids; exhibits strong binding to phosphatidic acid and weak binding to phosphatidylinositol 3- phosphate (PubMed:11279184). Binds 25-hydroxycholesterol (PubMed:17428193). {ECO:0000269|PubMed:11279184, ECO:0000269|PubMed:17428193}.;

Recessive Scores

pRec
0.105

Intolerance Scores

LoFtool
0.608
RVIS EVS
-0.6
RVIS percentile EVS
18.06

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.757

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.